| ECM-receptor interaction |
2 |
2 |
1.36E-05 |
HSPG2, COL4A2 |
| Glycerolipid metabolism |
8 |
3 |
5.46E-05 |
PPAP2B, DGKB, LIPC |
| Glycerophospholipid metabolism |
8 |
3 |
5.46E-05 |
PPAP2B, DGKB, ACHE |
| Ether lipid metabolism |
2 |
1 |
1.36E-05 |
PPAP2B |
| Sphingolipid metabolism |
2 |
1 |
1.36E-05 |
PPAP2B |
| Fc gamma R-mediated phagocytosis |
3 |
2 |
2.05E-05 |
PPAP2B DNM3 |
| Cytokine-cytokine receptor interaction |
4 |
4 |
2.73E-05 |
LEPR, TGFB2, IL2RA, CCL11 |
| Neuroactive ligand-receptor interaction |
6 |
6 |
4.09E-05 |
LEPR, PTGER3, GABRB1, GRM8, LPAR2, GRIK1 |
| Jak-STAT signaling pathway |
3 |
3 |
2.05E-05 |
LEPR, SPRED2, IL2RA |
| Adipocytokine signaling pathway |
2 |
2 |
1.36E-05 |
LEPR, PPARGC1A |
| Calcium signaling pathway |
5 |
4 |
3.41E-05 |
PTGER3, SLC8A1, CACNA1C, ITPR2 |
| Cell adhesion molecules |
3 |
2 |
2.05E-05 |
NEGR1, CNTN1 |
| Wnt signaling pathway |
7 |
6 |
4.77E-05 |
VANGL1, PRICKLE2, CTBP2, SMAD3, NFATC3, NFATC2 |
| Dorso-ventral axis formation |
2 |
2 |
1.36E-05 |
NOTCH2, ETV6 |
| Notch signaling pathway |
2 |
2 |
1.36E-05 |
NOTCH2, CTBP2 |
| Endocytosis |
4 |
4 |
2.73E-05 |
DNM3, IL2RA, USP8, GIT1 |
| MAPK signaling pathway |
6 |
6 |
4.09E-05 |
TGFB2, MRAS, MAP4K2, CACNA1C, FGF14, NFATC2 |
| Cell cycle |
5 |
3 |
3.41E-05 |
TGFB2, E2F3, SMAD3 |
| TGF-beta signaling pathway |
3 |
2 |
2.05E-05 |
TGFB2, SMAD3 |
| Pathways in cancer |
11 |
9 |
7.5E-05 |
TGFB2, PPARG, E2F3, CTBP2, IGF1, FGF14, COL4A2, SMAD3, DCC |
| Colorectal cancer |
4 |
3 |
2.73E-05 |
TGFB2, SMAD3, DCC |
| Pancreatic cancer |
5 |
3 |
3.41E-05 |
TGFB2, E2F3, SMAD3 |
| Chronic myeloid leukemia |
6 |
4 |
4.09E-05 |
TGFB2, E2F3, CTBP2, SMAD3 |
| Hypertrophic cardiomyopathy |
7 |
6 |
4.77E-05 |
TGFB2, SLC8A1, TTN, ACTB, CACNA1C, IGF1 |
| Dilated cardiomyopathy |
7 |
6 |
4.77E-05 |
TGFB2, SLC8A1, TTN, ACTB, CACNA1C, IGF1 |
| O-Glycan biosynthesis |
2 |
2 |
1.36E-05 |
GALNT2, C1GALT1 |
| Cardiac muscle contraction |
3 |
2 |
2.05E-05 |
SLC8A1, CACNA1C |
| Arrhythmogenic right ventricular cardiomyopathy |
5 |
4 |
3.41E-05 |
SLC8A1, ACTB, CACNA1C, PKP2 |
| Ubiquitin mediated proteolysis |
2 |
2 |
1.36E-05 |
FANCL, UBE2R2 |
| PPAR signaling pathway |
2 |
2 |
1.36E-05 |
PPARG, EHHADH |
| Huntington's disease |
5 |
4 |
3.41E-05 |
PPARG, DNAH1, PPARGC1A, CREB5 |
| Valine, leucine and isoleucine biosynthesis |
2 |
2 |
1.36E-05 |
LARS2, EHHADH |
| Aminoacyl-tRNA biosynthesis |
2 |
2 |
1.36E-05 |
LARS2, CARS |
| Axon guidance |
6 |
6 |
4.09E-05 |
ROBO2, UNC5C, ABLIM1, NFATC3, DCC, NFATC2 |
| Tight junction |
3 |
3 |
2.05E-05 |
MRAS, ACTB, SYMPK |
| Regulation of actin cytoskeleton |
4 |
4 |
2.73E-05 |
MRAS, ACTB, FGF14, GIT1 |
| Insulin signaling pathway |
2 |
2 |
1.36E-05 |
PPARGC1A, GCK |
| Lysosome |
3 |
3 |
2.05E-05 |
MANBA, IGF2R, CTSZ |
| Glioma |
2 |
2 |
1.36E-05 |
E2F3, IGF1 |
| Prostate cancer |
3 |
3 |
2.05E-05 |
E2F3, CREB5, IGF1 |
| Melanoma |
4 |
3 |
2.73E-05 |
E2F3, IGF1, FGF14 |
| Bladder cancer |
2 |
1 |
1.36E-05 |
E2F3 |
| Small cell lung cancer |
3 |
2 |
2.05E-05 |
E2F3, COL4A2 |
| Non-small cell lung cancer |
2 |
1 |
1.36E-05 |
E2F3 |
| Chondroitin sulfate biosynthesis |
2 |
2 |
1.36E-05 |
DSE, CSGALNACT1 |
| Focal adhesion |
3 |
3 |
2.05E-05 |
ACTB, IGF1, COL4A2 |
| Adherens junction |
4 |
3 |
2.73E-05 |
ACTB, PTPRB, SMAD3 |
| Vibrio cholerae infection |
5 |
2 |
3.41E-05 |
ACTB, KCNQ1 |
| Phosphatidylinositol signaling system |
6 |
2 |
4.09E-05 |
DGKB, ITPR2 |
| Type II diabetes mellitus |
2 |
2 |
1.36E-05 |
GCK, CACNA1C |
| Maturity onset diabetes of the young |
3 |
3 |
2.05E-05 |
GCK, HNF1A, HNF4A |
| Vascular smooth muscle contraction |
2 |
2 |
1.36E-05 |
CACNA1C, ITPR2 |
| Long-term potentiation |
2 |
2 |
1.36E-05 |
CACNA1C, ITPR2 |
| GnRH signaling pathway |
2 |
2 |
1.36E-05 |
CACNA1C, ITPR2 |
| Alzheimer's disease |
2 |
2 |
1.36E-05 |
CACNA1C, ITPR2 |
| Oocyte meiosis |
2 |
2 |
1.36E-05 |
ITPR2, IGF1 |
| Long-term depression |
2 |
2 |
1.36E-05 |
ITPR2, IGF1 |
| VEGF signaling pathway |
2 |
2 |
1.36E-05 |
NFATC3, NFATC2 |
| Natural killer cell mediated cytotoxicity |
2 |
2 |
1.36E-05 |
NFATC3, NFATC2 |
| T cell receptor signaling pathway |
2 |
2 |
1.36E-05 |
NFATC3, NFATC2 |
| B cell receptor signaling pathway |
2 |
2 |
1.36E-05 |
NFATC3, NFATC2 |
